comparemela.com

Latest Breaking News On - Richard quek - Page 1 : comparemela.com

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST QINLOCK significantly reduced the risk of disease progression or death by 85% and showed clinically meaningful overall survival in the INVICTUS Phase 3 Study1,2 SINGAPORE, May 8, 2023 /PRNewswire/ Independent biopharmaceutical company Specialised Therapeutics Asia (ST) is pleased to.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.